Diaceutics (GB:DXRX) has released an update.
Graham Paterson, a Non-Executive Director at Diaceutics PLC, has increased his stake in the company with the purchase of 39,934 ordinary shares at £1.2889 each, now holding a total of 73,498 shares. This acquisition, which constitutes a 0.09% ownership in the pharma and biotech solutions provider, reflects growing insider confidence and occurred on the AIM Market of the London Stock Exchange.
For further insights into GB:DXRX stock, check out TipRanks’ Stock Analysis page.
